BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026
MISSISSAUGA, Ontario, March 12, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. ('BioSyent”, 'the Company”, TSX Venture: RX) will be reporting its financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, March 19, 2026 after market hours. A presentation on the Company’s fourth quarter and full year 2025 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release.